Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Feb 05, 2018 $47.07 $48.07 $44.63 $45.22 74 223
Feb 02, 2018 $49.31 $49.60 $47.60 $48.18 54 757
Feb 01, 2018 $49.19 $50.68 $49.08 $49.91 70 912
Jan 31, 2018 $51.03 $53.51 $48.61 $49.12 83 049
Jan 30, 2018 $50.00 $52.00 $48.50 $49.76 135 453
Jan 29, 2018 $53.87 $54.62 $50.56 $50.78 153 102
Jan 26, 2018 $54.43 $55.46 $52.00 $53.84 189 987
Jan 25, 2018 $50.64 $56.56 $50.64 $55.47 195 203
Jan 24, 2018 $48.61 $51.24 $47.81 $50.40 145 360
Jan 23, 2018 $50.00 $50.00 $48.43 $49.10 192 828
Jan 22, 2018 $43.15 $51.38 $43.15 $50.02 474 478
Jan 19, 2018 $43.12 $43.40 $41.50 $43.00 622 880
Jan 18, 2018 $42.92 $43.99 $40.98 $42.46 155 509
Jan 17, 2018 $44.00 $44.25 $42.50 $43.26 171 853
Jan 16, 2018 $44.47 $46.51 $43.98 $45.05 155 135
Jan 15, 2018 $44.16 $44.16 $44.16 $44.16 0
Jan 12, 2018 $44.02 $45.18 $43.35 $44.16 28 221
Jan 11, 2018 $44.03 $44.89 $43.63 $44.02 45 634
Jan 10, 2018 $43.17 $44.20 $42.16 $43.67 20 157
Jan 09, 2018 $43.50 $44.67 $42.74 $43.44 25 763
Jan 08, 2018 $44.80 $44.85 $41.95 $43.00 83 086
Jan 05, 2018 $42.50 $46.08 $41.65 $43.97 98 715
Jan 04, 2018 $44.59 $44.59 $41.56 $42.85 141 574
Jan 03, 2018 $39.08 $46.68 $39.08 $44.58 268 817
Jan 02, 2018 $38.32 $39.45 $37.53 $38.64 96 917
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT